“康膝汤”治疗膝骨性关节炎的临床观察
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
研究背景:膝骨性关节炎(osteoarthritis,OA)是一种以膝关节软骨退行性变和关节周围骨质增生为病理性特征的慢性进行性骨关节病,临床以关节疼痛、肿胀、僵硬及功能障碍等为主要表现,从而给患者带来了生活和工作上的诸多不便,严重影响生活质量。随着人口老龄化程度的加剧,OA发病率也呈逐年上升趋势。祖国医学多将其归属于“骨痹”,近些年来无论是中医还是现代医学在该疾病的理论和临床方面均进行了较为深入的研究。目前,西药的治疗效果一般,且副作用较多,花费巨大,给患者带来了精神和经济负担。中医药治疗本病疗效较为显著,且无明显毒副作用,费用低廉,在临床上受到广大患者欢迎。
     目的:本临床研究旨在通过运用“康膝汤”治疗膝骨关节炎,经对比观察,探讨“康膝汤”在临床上对膝骨关节炎的疗效。
     方法:选择因膝OA至江苏省中西医结合医院骨伤科门诊就诊的病人42例。将42例患者分为治疗组(康膝汤组)22例和对照组(西药组)20例。运用疼痛视觉模拟量表(VAS)与膝骨性关节炎严重性指数(Lequesne),观察治疗前后疼痛及临床疗效。
     结果:Lequesne评分,治疗组有效16例,无效6例,总有效率72.73%;对照组有效18例,无效2例,总有效率90%,两组在改善临床疗效上无明显差异(P>0.05)。VAS评分,治疗组显效3例,有效9例,无效10例,总有效率54.55%;对照组显效11例,有效7例,无效2例,总有效率90%,治疗组与对照组在减轻疼痛程度上差异有显著统计意义(P<0.01)。
     结论:“康膝汤”及西药(西乐葆+留普安)在改善膝OA患者疼痛及临床症状方面均有显著疗效;但西药在控制患者膝关节疼痛方面优于“康膝汤”。
Background:Knee osteoarthritis is chronic progressive joint disease for pathological features of knee cartilage degeneration and joint surrounding bone hyperplasia.Its main clinical performance is joint pain, swelling stiff and dysfunction,and it brings patients the inconvenience of life and work, even affects the quality of life seriously.With the degree of population aging increasing,incidence of osteoarthritisincreased year by year.Traditional chinese medicine attributed the disease mainly to "Gubi'In recent years,Both Chinese medicine and modern medicine have conducted more thorough research in the aspects theory and clinical of disease.Currently,Treatment of western medicine is not effective as will,meanwhile accompanied by sorts of side effects and mass of cost, gave patients has brought the spirit and economic burden,bringing about mental and economic burden. Chinese medicine treatment is more efficacious in this disease,with no obvious side effects and low-cost, is welcomed by the majority of patients in clinical.
     Objective:This clinical research was designed to treat osteoarthritis by the use of "Kang Xi Tang",through contrast observation,to explore its curative effect of knee osteoarthritis.
     Methods:42 patients from Jiangsu Province Hospital on Integration of Chinese and Western Medicine are divided into treatment group (Kang Xi Tang)with 22 cases and the control group (western medicine) with 20 cases.To observe pain and clinical efficacy before and after treatment by the use of visual analogue scale(VAS) score and Lequesne knee score.
     Result:Lequesne knee score,16 cases effective and 6 cases non-effective in treatment group,the total effective rate is 72.73%;in the control group,the treatment produces 18 cases effective and 2 cases non-effective,the total effective rate is 90%.In comparision,there is no significant difference in imporving the clinical efficacy(P>0.05).VAS score,3 cases significantly effective,9 cases effective and 10 cases non-effective in treatment group,the total effective rate is 54.55%; 11 cases significantly effective,7. cases effective and 2 cases non-effective in the control group,the total effective rate is 90%.In comparision,there is no significant difference in imporving the clinical efficacy(P>0.05).In comparision,there is a significant difference in relieving pain(P<0.01).
     Conclusion:Both "Kang Xi Tang" and western medicine(Celebrex and Liupuan) have a significant effect on relieving pain and imporving clinical symptoms for patients with knee OA.However,western medicine produces better efficacy than "Kang Xi Tang" on the knee pain of patients.
引文
[1]HUTER D J,ZHANG Y, NIU J,et al. Stuctural fact or s associated with mal alignment in knee osteoarthritis: the Bost on oeteoarthrit is kn ee study[J]J Rheumatol,2005,32(11):2192-2199
    [2]邱贵兴.骨关节炎流行病学和病因学新进展[J].继续医学教育,2005,19(7):68-69.
    [3]杨静,孙官军,裴福兴,等.四川省部分地区汉族中老年人骨关节炎的流行病学研究[J].中国骨与关节损伤杂志,2010,25(8):693-696.
    [4]林锦洪,李敏健,许智源,等.广州市社区18个居委会45岁以上人群退行性膝关节病的流行病学调查[J].中国临床康复,2005,47:8-9.
    [5]Anderson JJ,Felson DT.Factors associated with osteoarthritis of the knee in the first national health and nutrition examination survey (HANES I).Evidence for an association with overweight, race, and physical demands of work [J]. Am J Epidemiol,1988,128(1):179-189.
    [6]Powell A,Teichtahl AJ,W luka AE, et al. Obesity:a preventable risk factor for large joint osteoarthritis which may act through biomechanical factors[J]. Br J SportsMed,2005,39 (1):4-5.
    [7]Felson DT,Zhang Y.An update On the epidomiology of knee and hip osteoarthritis with a view to prevention[J].Arthritis Rheum,1998,141(8):1343-1345.
    [8]曹月龙,高宁阳,庞坚,等.国际骨关节炎研究学会髋与膝骨关节炎治疗指南——第二部分:基于循证和专家共识之治疗指南[J].国际骨科学杂志,2009,30(4):208-217.
    [9]王平乐.补肾活血治疗骨性关节炎92例[J].中国民族民间医药,2010,6:116.
    [10]甘小明.独活寄生汤加减治疗膝关节骨性关节炎60例[J].湖南中医杂志,2010,26(2):61-62.
    [11]苏雅虹.活血化瘀法加补肾法治疗膝关节骨性关节炎的临床研究[J].中国中医骨伤科杂志,2006,12(S2):30-37.
    [12]韩新峰,杜天信,李无阴.湿热痹颗粒治疗湿热痹阻型风湿病的临床观察[J].中医正骨,2002,14(4):9-11.
    [13]邓伟.补脾益肾化瘀法治疗膝骨关节炎[J].中药材,2003,26(7):535-537.
    [14]刘佩凤.中药外敷治疗膝骨性关节炎68例[J].中国民间疗法,2010,18(3):19.
    [15]陈永强,吴军豪,姚宏明等.复方南星止痛膏治疗寒湿瘀阻型骨关节炎249例临床研究[J].上海中医药杂志,2010,44(12):59-61.
    [16]林青松.中药熏洗治疗膝关节骨关节炎202例[J].中国民间疗法,2010,18(10):22.
    [17]张连记,孔祥庚,郭祥坤,等.筋骨腾药热熨法治疗骨质增生症400例[J].中国民间疗法,2004,12(11):24-25.
    [18]任艳君.透刺法治疗膝关节骨性关节炎[J].中国针灸,2003,23(6):348.
    [19]吴明霞,李俐,洪昆达,等.温针灸治疗膝骨性关节炎30例[J].福建中医学院学报,2007,6(17):37-38.
    [20戴建民.针刀治疗膝关节骨性关节炎32例疗效观察[J].临床医药实践,2010,19(1):27-47.
    [21]马荣连,徐小梅,胡树罡,等.小针刀配合等速肌力训练治疗老年膝骨性关节炎的结果分析[J].实用老年医学,2010,24(4):300-302.
    [22]陈利新,马少云,莫卫海.中药离子导人治疗膝关节骨性关节炎400例临床报告[J].医学理论与实践,2003,16(5):557-558.
    [23]庞江虎.中西医结合治疗膝关节骨性关节炎150例疗效观察[J].航空航天医药,2010,21(12):2271-2272.
    [24]涂世玉,韩晓强,王祖安,等.针灸推拿结合中药治疗膝骨性关节炎60例[J].现代中医药,2010,30(5):70-71.
    [25]张鹏.中西医结合治疗膝关节骨性关节炎临床疗效研究[J].时珍国医国药,2010,21(7):1837-1838.
    [26]汤治黎,章汉平,李源,等.丹参注射液诱导大鼠骨髓间充质干细胞分化为成软骨细胞的研究[J].湖北中医杂志,2008,30(6):11-12.
    [27]尚平,贺宪,安耀武,等.骨碎补总黄酮对骨关节炎家兔骨髓间充质干细胞软骨定向分化的实验研究[J].生物骨科材料与临床研究,2009,6(6):10-13.
    [28]刘献祥,李明波,陈文列,等.透骨消痛颗粒对BMSCs向软骨细胞分化的影响[J].福建中医学院学报,2009,19(4):33-37.
    [29]杜建伟,种清治,谢梅兰.骨舒汤对实验性膝骨关节炎家兔软骨细胞凋亡的影响[J].现代中医药,2010,30(2):57-58.
    [30]陈德喜,郎继孝,李沂红,等.壮骨颗粒对骨关节炎兔去分化软骨细胞影响的实验研究[J].中国伤残医学,2009,17(2):4-7.
    [31]周琦石,郑晓辉等.补肾益气行血方药对人类骨关节炎软骨细胞Ⅱ型胶原和一氧化氮合酶的影响[J].中医药通报,2007,6(4):50-56.
    [32]温进中,高虎元,姚苏理.补肝益肾法结合玻璃酸钠关节内注射对膝骨关节炎关节液中蛋白多糖影响的临床对照试验[J].中国骨伤,2007,20(12):859-860.
    [33]邵斌.丹参注射液治疗骨内高压症的实验研究[J].山东医药,2006,46(20):26-27.
    [34]叶俊星,白书臣,吉璐宏.骨痛胶囊对日本大耳白兔膝骨内高压和血液流变学作用的实验研究[J].中国中医骨伤科杂志,2007,15(2):45-48.
    [35]周达岸,郑洪新,李静.骨痹消对兔骨关节炎软骨、滑膜组织病理学变化的影响[J].数理医药学杂志,2010,23(2):206-208.
    [36]张鹏,石关桐,郑昱新,等.补肾方、柔肝方与化痰方对膝骨关节炎滑膜细胞增殖及COMP表达的影响[J].中国中医骨伤科杂志,2008,16(12):18-21.
    [37]齐立卿,杜景华,杜双庆.养元柔肝汤对兔膝骨性关节炎模型滑液中TNF-α、HA的影响[J].河北中医,2009,31(7):1066-1067.
    [38]王雁录,王伟亮,唐自银,等.仙灵骨葆胶囊对膝骨性关节炎患者关节液SOD和MDA水平的影响[J].陕西医学杂志,2008,37(7):892-893.
    [39]袁文旗,王洪,赵玉鑫,等.黄芪关节腔内注射后兔骨关节炎模型软骨退行性变及滑膜组织中超氧化物歧化酶活性的变化[J].中国临床康复,2006,10(39):92-93.
    [40]钟玉,李荣享.复元胶囊对实验性兔骨关节炎自介素1及转化生长因子β2的调节作用[J].重庆医科大学学报,2007,32(8),856-873.
    [41]方锐,孟庆才,邓迎杰,等.膝骨关节炎患者血清和关节液中基质金属蛋白酶1,3、基质金属蛋白酶抑制剂1及白细胞介素1-β含量与补肾通络方的干预[J].中国组织工程研究与临床康复,2008,12(28):5581-5585.
    [42]姜楠,王玉明,刘密凤,等.清热养阴除湿丸对Ⅱ型胶原诱导性关节炎大鼠治疗作用及机制的研究[J].北京中医药,2010,29(3):228-230.
    [43]唐勇,姜杰,孟辉,等.补肾益气活血方含药血清对兔软骨细胞增殖和bFGF-mRNA表达的影响[J].时珍国医国药,2006,17(5):686-687.[44]陈百成,张静.骨关节炎[M].北京:人民卫生出版社,2004:18-20.[45]Lequesne MG,Samson M.Incidices of severity in osteoarthritis for weight hearing joints[J].J Rheumatol,1991,18(supple 27):16-18.